5 Healthcare Stocks with Highest Dividends

2. Embecta Corp. (NASDAQ:EMBC)

Dividend Yield as of April 15: 6.24%

On April 13, Mizuho lowered its price recommendation on Embecta Corp. (NASDAQ:EMBC) to $12 from $14. It reiterated a Neutral rating on the shares. The change came as the firm adjusted estimates and targets across several medical devices and diagnostics names ahead of Q1 earnings.

The same day, BTIG also updated its view. It lowered its price target on Embecta to $22 from $25 while maintaining a Buy rating, as part of a broader research note on medical technology. BTIG said it is revising its models following the CMS proposed rule for the FY27 inpatient prospective payment system. The update includes early commentary and decisions tied to new technology add-on payments, according to the analyst.

Earlier in March, Embecta said it had reached a definitive agreement to acquire Owen Mumford Holdings Limited, a UK-based company known for its work in medical devices and drug-delivery technologies. Under the deal, Embecta will pay £100 million in cash at closing, with the final amount subject to customary adjustments. The agreement also includes up to £50 million in additional payments, tied to how the Aidaptus next-generation auto-injector platform performs over the three years after closing.

The company’s Board of Directors approved the transaction unanimously. It is expected to close in Embecta’s fiscal third quarter of 2026, pending regulatory approvals and other standard conditions.

Embecta Corp. (NASDAQ:EMBC) operates as a global diabetes care company, focused on supporting people living with diabetes. Its portfolio includes pen needles, syringes, and safety injection devices, along with a digital application designed to help patients manage their condition.